Idiopathic retroperitoneal fibrosis: A role for mycophenolate mofetil

Clinical Nephrology

Volumn 69, Issue 4, 2008, Pages 260-268

  Swartz, R D ^a   Lake, A M ^b   Roberts, W W ^b   Faerber, G J ^b   Wolf Jr , J S ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Corticosteroids; Mycophenolate mofetil; Retroperitoneal fibrosis; Urinary tract obstruction

Indexed keywords

CORTICOSTEROID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BACKACHE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; DIVERTICULITIS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; HYDRONEPHROSIS; INTESTINE ISCHEMIA; MALE; NEPHRECTOMY; NEPHROSTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREATITIS; RETROPERITONEAL FIBROSIS; SEROLOGY; URETER STENT; URINARY TRACT BIOPSY;

EID: 42049089295     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP69260     Document Type: Article

References (29)

1. Bleumink G, Van der Molen-Eijgenraam M, Strijbos J et al. Pergolide-induced pleuropulmonary fibrosis. Clin Neuropharmacol. 2002; 25: 290-293.
2. Buckberg G, Dilley R, Longmire W. The protean manifestations of sclerosing fibrosis. Surg Gyn Obstet. 1966; 4: 729-736.
3. Cerny J, Scott T. Non-idiopathic retroperitoneal fibrosis. J Urol. 1971; 105: 49-55.
4. Ciubotaru V, Poinsignon Y, Brunet-Bourgin F et al. Severe pleuropericarditis induced by long-term bromocriptine therapy. Rev Med Interne. 2004; 25: 3 10-314.
5. Cogan E, Fastrez R. Azathioprine-an alternative treatment for recurrent idiopathic retroperitoneal fibrosis. Arch Int Med. 1985; 145: 753-755.
6. Corradi D, Maestri R, Palmison A, Bosio S, Greco P, Maneti L, Ferreti S, Corelli R, Moreni G, Dei Tos A, Buzio C, Vaglio A. Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis. Kidney Int. 2007; 72: 742-753.
7. Dash R, Liu K, Sheafor D, Dodd L. Fine-needle aspiration findings in idiopathic retroperitoneal fibrosis. Diagn Cytopathol. 1999; 21: 22-26.
8. Flynn J, Greco J. Retroperitoneal fibrosis and methyldopa. N Engl J Med. 1976; 295: 112.
9. Graham J, Selby H, LeCompte P et al. Fibrotic disorders associated with methysergide therapy for headache. N Engl J Med. 1966; 274: 359-368.
10. Grotz W, von Zedtwitz I, Andre M, Schollmeyer P. Treatment of retroperitoneal fibrosis by mycophenolate mofetil and corticosteroids. Lancet. 1998; 352: 1195.
11. Harreby M, Bilde T, Helin P, Meyhoff H, Vinterberg H, Nielson V. Retroperitoneal fibrosis treated with methylprednisolone pulse and disease-modifying anti-rheumatic drugs. Scand J Urol Nephrol. 1994; 28: 237-242.
12. Henry L, Doust B, Korns M, Bernhard V. Abdominal aortic aneurysm and retroperitoneal fibrosis. Arch Surg. 1978; 113: 1456-1460.
13. Ilie C, Pemberton R, Tolley D. Idiopathic retroperitoneal fibrosis: the case for non-surgical treatment. Br J Urol. 2006; 98: 137-140.
14. Izzedine H, Servais A, Launay-Vacher V, Deray G. Retroperitoneal fibrosis due to Wegener's granulomatosis: a mis-diagnosis as tuberculosis. Am J Med. 2002; 113: 164-166.
15. Kaipiainen-Sappenen O, Jantunen E, Kuusisto J, Marin S. Retroperitoneal fibrosis with antineutrophil cytoplasmic antibodies. J Rheumatol. 1999; 23: 779-781.
16. Karder A, Kattan S, Lindstedt E, Hanash K. Steroid therapy for idiopathic retroperitoneal fibrosis: dose and duration. J Urol. 2002; 168: 550-555.
17. Morcolongo R, Tavolini I, Laveder F et al. Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases. Am J Med. 2004; 116: 194-197.
18. Mitchinson M, Bird D. Urinary leakage and retroperitoneal fibrosis. J Urol. 1971; 105: 56-68.
19. Moody T, Vaughan E. Steroids in the treatment of retroperitoneal fibrosis. J Urol. 1979; 121: 109-111.
20. Morad N, Strongwater S, Eypper S, Woda B. Idiopathic retroperitoneal and mediastinal fibrosis mimicking connective tissue disease. Am J Med. 1987; 82: 363-366.
21. Morandi L, Grob P. Retroperitoneal fibrosis: response to corticosteroid therapy. Arch Intern Med. 1971; 128: 295-298.
22. Ormond J. Bilateral ureteral obstruction due to envelopment and compression by an inflammatory retroperitoneal process. J Urol. 1948; 59: 1072-1079.
23. Puce R, Porcaro A, Curti P et al. Treatment of retroperitoneal fibrosis with tamoxifen: case report and review of the literature. Arch Espan Urol. 2000; 53: 184-190.
24. Tallarigo C, D'Amico A, Porcaro A et al. Our experience in the treatment of retroperitoneal fibrosis. Arch Ital Urol Androl. 2000; 72: 51-58.
25. van Bommel E. Retroperitoneal fibrosis. Neth J Med. 2002; 60: 231-242.
26. van Bommel E, Hendriksz T, Huiskes A, Zeegers A. Brief communication: tamoxifen therapy for non-malignant retroperitoneal fibrosis. Ann Intern Med. 2006; 144: 101-106.
27. van Bommel E, Siemes C, Hak L, van der Veen S, Hendriksz T. Long-term renal and patient outcomes in idiopathic retroperitoneal fibrosis treated with prednisone. Am J Kidney Dis. 2007; 49: 615-625.
28. Vest S, Barelare B. Peri-ureteritis plastica: a report of four cases. J Urol. 1953; 70: 38-50.
29. Warnatz K, Keskin A, Uhl M et al. Immunosuppressive treatment of chronic periaortitis: retrospective study of 20 patients with chronic periaortitis and a review of the literature. Ann Rheum Dis. 2005; 64: 823-833.